EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F18%3A10375294" target="_blank" >RIV/00216208:11110/18:10375294 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216224:14110/18:00102047 RIV/00216208:11130/18:10375294 RIV/00216208:11140/18:10375294 RIV/00216208:11150/18:10375294 a 8 dalších

Výsledek na webu

<a href="https://doi.org/10.1111/crj.12700" target="_blank" >https://doi.org/10.1111/crj.12700</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1111/crj.12700" target="_blank" >10.1111/crj.12700</a>

Jazyk výsledku

angličtina

Název v původním jazyce

EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis

Popis výsledku v původním jazyce

IntroductionPrognostic factors of idiopathic pulmonary fibrosis (IPF) currently recognized include changes in vital capacity and radiologic findings. However, most of the prognostic studies in IPF are based on clinical studies with preselected IPF populations. Therefore, we decided to analyze the factors influencing IPF prognosis based on the real-practice data from our IPF registry. MethodsData of 514 subjects consecutively entered since 2012 into Czech EMPIRE IPF registry were analyzed. ResultsMedian age of our patient cohort was 67 years (50-82). Median overall survival (OS) of the cohort was 63.1 months. The clinical course of IPF according to FVC (forced vital capacity) changes was stabilized in 32.8% of patients (29.7% according to DLCO [diffuse lung capacity] changes), slowly progressive in 39.5% (45%), rapidly progressive in 23.5% (20.7%); and 1.7% patients had at least one acute exacerbation during follow-up. Deterioration in FVC of 10% at month 12 and in DLCO of 15% at months 12, 18, and 24 influenced the OS significantly. The fast progressors defined by the DLCO decline rate had higher risk of death compared to those defined by the FVC change over time. In multivariate analysis, age 70 years, interstitial HRCT scores 3, and change in DLCO of 15% at month 12 were confirmed as factors negatively influencing OS. ConclusionsDL(CO) changes over time were shown as a better predictor of mortality compared with FVC changes in our study. In our opinion it is necessary to implement the DLCO analysis into clinical trials and routine practice.

Název v anglickém jazyce

EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis

Popis výsledku anglicky

IntroductionPrognostic factors of idiopathic pulmonary fibrosis (IPF) currently recognized include changes in vital capacity and radiologic findings. However, most of the prognostic studies in IPF are based on clinical studies with preselected IPF populations. Therefore, we decided to analyze the factors influencing IPF prognosis based on the real-practice data from our IPF registry. MethodsData of 514 subjects consecutively entered since 2012 into Czech EMPIRE IPF registry were analyzed. ResultsMedian age of our patient cohort was 67 years (50-82). Median overall survival (OS) of the cohort was 63.1 months. The clinical course of IPF according to FVC (forced vital capacity) changes was stabilized in 32.8% of patients (29.7% according to DLCO [diffuse lung capacity] changes), slowly progressive in 39.5% (45%), rapidly progressive in 23.5% (20.7%); and 1.7% patients had at least one acute exacerbation during follow-up. Deterioration in FVC of 10% at month 12 and in DLCO of 15% at months 12, 18, and 24 influenced the OS significantly. The fast progressors defined by the DLCO decline rate had higher risk of death compared to those defined by the FVC change over time. In multivariate analysis, age 70 years, interstitial HRCT scores 3, and change in DLCO of 15% at month 12 were confirmed as factors negatively influencing OS. ConclusionsDL(CO) changes over time were shown as a better predictor of mortality compared with FVC changes in our study. In our opinion it is necessary to implement the DLCO analysis into clinical trials and routine practice.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30203 - Respiratory systems

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2018

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

The Clinical Respiratory Journal

ISSN

1752-6981

e-ISSN

—

Svazek periodika

12

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

10

Strana od-do

1526-1535

Kód UT WoS článku

000429581600025

EID výsledku v databázi Scopus

2-s2.0-85045122005